In-licensed product Natulan® (Procarbazine Hydrochloride Capsules) was successfully launched in China

April 24, 2023, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950) announced that its in-licensed product Natulan® (Procarbazine Hydrochloride Capsules, formerly known as Procarbazine), was successfully launched in China and was distributed from its Guangzhou Nansha manufacturing site across the country.

The release as fetched from its publisher. leespharm.com ↗